PMAQX | POAGX | PMAQX / POAGX | |
Total Expense Ratio | 0.59 | 0.66 | 89% |
Annual Report Gross Expense Ratio | 0.59 | 0.66 | 89% |
Fund Existence | 9 years | 21 years | - |
Gain YTD | 2.039 | 0.976 | 209% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 30.6B | 6.19B | 495% |
Annual Yield % from dividends | 0.19 | 0.03 | 752% |
Returns for 1 year | 10.62 | -3.66 | -291% |
Returns for 3 years | 50.92 | 19.65 | 259% |
Returns for 5 years | 56.82 | 2.98 | 1,904% |
Returns for 10 years | N/A | 26.37 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDNI | 33.29 | N/A | N/A |
First Trust Dow Jones Intl Intnt ETF | |||
JAAA | 50.65 | -0.01 | -0.02% |
Janus Henderson AAA CLO ETF | |||
GHYG | 45.45 | -0.15 | -0.32% |
iShares US & Intl High Yield Corp Bd ETF | |||
BNDW | 68.77 | -0.23 | -0.33% |
Vanguard Total World Bond ETF | |||
HQL | 12.85 | -0.13 | -1.00% |
abrdn Life Sciences Investors |